Latin America Cancer Care Access: Knight Therapeutics signed an exclusive distribution deal with Kyowa Kirin to commercialize mogamulizumab (POTELIGEO) for cutaneous T-cell lymphoma in Brazil, Mexico, Colombia and Argentina, aiming to speed access after regulatory approvals. Pediatric Oncology & Prevention: In Antigua and Barbuda, a doctor urged annual child health checks to catch cancer early, citing the lack of a resident pediatric cancer specialist and the need for families to travel abroad for diagnosis and treatment. Community Screening in the Caribbean: The Antigua Barbuda Red Cross expanded its Community Life Line with free blood pressure and glucose checks plus counseling, reaching bus stations, Barbuda and vulnerable groups. Public Health Workforce & Data Use: An Antiguan nurse returned with an MPH and a plan to shift health priorities toward data-driven prevention, focusing on childhood obesity in the first 1,000 days. Heat & Health Risks: A new study says the global heatwave season has stretched by about 39 days since 1979, arriving earlier and lasting longer—raising risks for hospitals and communities. Cardiovascular Disparities: A scientific statement highlights that cardiovascular disease has become the leading cause of death among Hispanic Americans, driven by gaps in risk-factor recognition, management and access to care. Gambling and Health: Brazil’s Lula moved to ban fixed-odds betting platforms ahead of elections, with health workers warning about addiction impacts. GERD Treatment Trial: Phathom Pharmaceuticals started a registrational Phase 3 study of VOQUEZNA (vonoprazan) for as-needed treatment of non-erosive GERD, with topline results expected in early 2028.